SCHEMBL5697443

SCHEMBL5697443

C[C@]12C(O)=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.51
NR3C1 P04150 5/20 0.51
SHBG P04278 4/20 0.51
CYP2C19 P33261 4/20 0.51
SERPINA6 P08185 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
BLM P54132 2/20 0.51
MAPT P10636 2/20 0.51
ADORA3 P0DMS8 1/20 0.51
MAPK3 P27361 1/20 0.51
SLC6A3 Q01959 1/20 0.51
HSD17B10 Q99714 7/20 0.48
HIF1A Q16665 5/20 0.48
CYP3A4 P08684 2/20 0.48
TSHR P16473 2/20 0.48
PMP22 Q01453 1/20 0.48
PGR P06401 4/20 0.44
ALDH1A1 P00352 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26133329 1.00 LMNA (0.51) LMNANR3C1SHBGCYP2C19SERPINA6
SCHEMBL3768042 0.91 LMNA (0.62) LMNANR3C1SHBGCYP2C19SERPINA6
SCHEMBL3726244 0.88 HSD17B10 (0.64) LMNANR3C1SHBGCYP2C19SERPINA6
SCHEMBL5459012 0.88 HSD17B10 (0.64) LMNANR3C1SHBGCYP2C19SERPINA6
SCHEMBL6334150 0.84 AR (0.43) LMNANR3C1SHBGCYP2C19SERPINA6
SCHEMBL10380227 0.81 LMNA (0.74) LMNANR3C1CYP2C19SERPINA6MEN1
SCHEMBL4556893 0.80 AR (0.43) LMNANR3C1SHBGCYP2C19SERPINA6
SCHEMBL536709 0.80 NR3C1 (0.52) LMNANR3C1SHBGCYP2C19SMN1; SMN2
SCHEMBL11295931 0.78 LMNA (0.47) LMNANR3C1SHBGCYP2C19SERPINA6
SCHEMBL4556901 0.77 HSD17B10 (0.45) LMNANR3C1SHBGCYP2C19SERPINA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658083-A1 ENHANCEMENT OF ACTIVITY AND/OR DURATION OF ACTION OF SELECTED ANTI-INFLAMMATORY STEROIDS BODOR, Nicholas S. (US) 2006-05-24 EP claimed
EP-1653974-A1 ENHANCEMENT OF ACTIVITY AND/OR DURATION OF ACTION OF SOFT ANTI-INFLAMMATORY STEROIDS FOR TOPICAL OR OTHER LOCAL APPLICATION BODOR, Nicholas S. (US) 2006-05-10 EP claimed
WO-2005000317-A1 ENHANCEMENT OF ACTIVITY AND/OR DURATION OF ACTION OF SOFT ANTI-INFLAMMATORY STEROIDS FOR TOPICAL OR OTHER LOCAL APPLICATION BODOR NICHOLAS S (US) 2005-01-06 WO claimed
WO-2004112800-A1 ENHANCEMENT OF ACTIVITY AND/OR DURATION OF ACTION OF SELECTED ANTI-INFLAMMATORY STEROIDS BODOR NICHOLAS S (US) 2004-12-29 WO claimed
EP-1658083-A1 ENHANCEMENT OF ACTIVITY AND/OR DURATION OF ACTION OF SELECTED ANTI-INFLAMMATORY STEROIDS BODOR, Nicholas S. (US) 2006-05-24 EP disclosed
EP-1653974-A1 ENHANCEMENT OF ACTIVITY AND/OR DURATION OF ACTION OF SOFT ANTI-INFLAMMATORY STEROIDS FOR TOPICAL OR OTHER LOCAL APPLICATION BODOR, Nicholas S. (US) 2006-05-10 EP disclosed
WO-2005000317-A1 ENHANCEMENT OF ACTIVITY AND/OR DURATION OF ACTION OF SOFT ANTI-INFLAMMATORY STEROIDS FOR TOPICAL OR OTHER LOCAL APPLICATION BODOR NICHOLAS S (US) 2005-01-06 WO disclosed
WO-2004112800-A1 ENHANCEMENT OF ACTIVITY AND/OR DURATION OF ACTION OF SELECTED ANTI-INFLAMMATORY STEROIDS BODOR NICHOLAS S (US) 2004-12-29 WO disclosed